CLINICAL TRIALS PROFILE FOR PERAMPANEL
✉ Email this page to a colleague
All Clinical Trials for Perampanel
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00368472 ↗ | 4-Year Open-Label Extension Phase of the Parallel-Group Study of E2007 in Patients With Refractory Partial Seizures | Completed | Eisai Inc. | Phase 2 | 2006-10-01 | The purpose of this study is to determine the safety of perampanel given as adjunctive, long-term treatment in patients with refractory partial onset seizures. |
| NCT00505284 ↗ | An Evaluation of the Efficacy and Safety of E2007 in Patients With Painful Diabetic Neuropathy | Completed | Eisai Limited | Phase 2/Phase 3 | 2007-06-01 | The purpose of this study is to determine the efficacy and safety of Perampanel in patients with painful diabetic neuropathy. |
| NCT00505284 ↗ | An Evaluation of the Efficacy and Safety of E2007 in Patients With Painful Diabetic Neuropathy | Completed | Eisai Inc. | Phase 2/Phase 3 | 2007-06-01 | The purpose of this study is to determine the efficacy and safety of Perampanel in patients with painful diabetic neuropathy. |
| NCT00505622 ↗ | Evaluation of the Long-term Safety, Tolerability, and Efficacy of Perampanel (E2007) as an Adjunctive Therapy in Levodopa Treated Parkinson's Disease Subjects With Motor Fluctuations | Terminated | Eisai Limited | Phase 3 | 2007-07-01 | This is a multicentre, open-label extension study to evaluate the long-term safety, tolerability, and efficacy of Perampanel (E2007) as an adjunctive therapy in levodopa treated PD subjects with motor fluctuations. All subjects who have completed E2007-E044-213 or E2007-G000-309 will be candidates for entering this extension trial, provided that they meet the inclusion/exclusion criteria and have completed the core study, up to and including the final efficacy visit. |
| NCT00566462 ↗ | Assessment of Perampanel (E2007) on Synaptic Dopamine in Mild-moderate PD Patients: A Pilot Study With [^123I]-IBZM SPECT | Terminated | Eisai Inc. | Phase 2 | 2007-10-01 | This is a two-arm, double-blind, placebo-controlled study. |
| NCT00592774 ↗ | Dose-Tolerability Titration Study to Evaluate The Efficacy And Safety Of Perampanel (E2007) In Patients With Post-Herpetic Neuralgia (PHN) | Completed | Eisai Inc. | Phase 2 | 2008-01-01 | The purpose of the study is to determine the efficacy and safety of Perampanel (E2007) in patients with Post-Herpetic Neuralgia (PHN). |
| NCT00592904 ↗ | Evaluating E2007 (Perampanel) in Patients With Painful Diabetic Neuropathy (PDN) or Post-Herpetic Neuralgia (PHN) | Completed | Eisai Inc. | Phase 2/Phase 3 | 2008-01-01 | The purpose of this study is to evaluate the safety, tolerability and continued efficacy of perampanel in patients previously enrolled in double-blind, placebo-controlled studies for Painful Diabetic Neuropathy (PDN) or Post-Herpetic Neuralgia (PHN). |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for Perampanel
Condition Name
Clinical Trial Locations for Perampanel
Trials by Country
Clinical Trial Progress for Perampanel
Clinical Trial Phase
Clinical Trial Sponsors for Perampanel
Sponsor Name
